|
|
|
|
Document Preview Asset Purchase Agreement |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Asset Purchase Agreement |
|||
|
Entities: |
Chase Manhattan Bank; Chase Securities Inc.; Pfizer, Inc.; Phibro Animal Health Corp; PNC Bank, NA; Smithkline Beecham plc; Weil, Gotshal & Manges LLP |
|||
|
Date: |
2000 |
|||
|
Size: |
Preview shows 5KB of 513KB total |
|||
|
Price: |
$99 |
|||
|
ID: |
#1577145 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
ASSET PURCHASE AGREEMENT
among
PFIZER INC.,
the
ASSET SELLING CORPORATIONS
(named herein)
and
PHILIPP BROTHERS CHEMICALS, INC.
DATED AS OF SEPTEMBER 28, 2000
TABLE OF CONTENTS
Page
ARTICLE I DEFINITIONS AND TERMS................................................1
Section 1.1 Definitions.............................................1
Section 1.2 Other Definitional Provisions..........................12
ARTICLE II PURCHASE AND SALE..................................................12
Section 2.1 Purchase and Sale of the Conveyed Assets...............12
Section 2.2 Consents...............................................14
Section 2.3 Retained Assets........................................15
Section 2.4 Assumption of Liabilities..............................16
Section 2.5 Retained Liabilities...................................17
Section 2.6 Purchase Price.........................................18
Section 2.7 Purchase Price Adjustment..............................21
Section 2.8 Production Margin Royalty Payments.....................23
Section 2.9 Allocation of the Purchase Price.......................25
ARTICLE III CLOSING...........................................................25
Section 3.1 Closing................................................25
ARTICLE IV CONDITIONS TO CLOSING..............................................26
Section 4.1 Conditions to the Obligations of Purchaser and Pfizer..26
Section 4.2 Conditions to the Obligations of Purchaser.............26
Section 4.3 Conditions to the Obligations of Pfizer................26
ARTICLE V REPRESENTATIONS AND WARRANTIES OF PFIZER............................27
Section 5.1 Organization...........................................27
Section 5.2 Authority; Binding Effect..............................28
Section 5.3 Non-Contravention......................................28
Section 5.4 Pfizer Consents and Approvals..........................29
Section 5.5 Financial Information..................................29
Section 5.6 Absence of Material Changes............................29
Section 5.7 No Litigation..........................................30
Section 5.8 Compliance with Laws...................................30
Section 5.9 Product Registrations; Regulatory Compliance...........30
Section 5.10 Environmental Matters..................................31
Section 5.11 Material Contracts.....................................32
i
TABLE OF CONTENTS
(continued)
Section 5.12 Intellectual Property..................................33
Section 5.13 Real Property..........................................33
Section 5.14 Assets.................................................34
Section 5.15 Employee Benefits......................................34
Section 5.16 No Questionable Payments...............................35
Section 5.17 Major Customers and Suppliers..........................35
Section 5.18 Brokers................................................36
Section 5.19 Taxes..................................................36
ARTICLE VI REPRESENTATIONS AND WARRANTIES OF PURCHASER........................36
Section 6.1 Organization and Qualification.........................36
Section 6.2 Corporate Authorization................................36
Section 6.3 Binding Effect.........................................36
Section 6.4 Non-Contravention......................................37
|
End of Preview |
Home Intelligence Services Subscriptions News About Us